Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By stimulating these receptors, https://jadalxpa532294.timeblog.net/72004051/setmelanotide-a-promising-new-treatment-for-obesity